Kareg Corporation Initiates Coverage on GenSpera (OTCQB:GNSZ) with a Speculative Buy Recommendation

www.Investorideas.com's picture
SAN ANTONIO - July 14, 2014 (Investorideas.com Biotech Newswire) GenSpera, Inc. (OTCQB:GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, announces that Kareg Corporation's Director of Research, Sheldon S. Traube, has issued the following research report on the company.